JTCS Speed Up Your Browser
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kameyama, K.
Right arrow Articles by Yokomise, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kameyama, K.
Right arrow Articles by Yokomise, H.
Related Collections
Right arrow Lung - cancer

J Thorac Cardiovasc Surg 2002;124:503-510
© 2002 The American Association for Thoracic Surgery


General Thoracic Surgery (GTS)

Problems related to TNM staging: Patients with stage III non–small cell lung cancer

Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto, MD, Eiichi Hayashi, MD, Yasumichi Yamamoto, MD, Hiroyasu Yokomise, MD

From the Second Department of Surgery, Kagawa Medical University, Kagawa, Japan.

Received for publication Aug 28, 2001. Revisions requested Dec 14, 2001; revisions received Dec 27, 2001. Accepted for publication Feb 5, 2002. Address for reprints: Hiroyasu Yokomise, MD, Kagawa Medical University, 1750-1, Miki-cho, Kita-gun, Kagawa 761-0793, Japan (E-mail: yokomise{at}kms.ac.jp).

Objective: Many reports have raised certain problems concerning the current TNM classification of lung cancer, namely that there is no sufficient difference in prognosis between patients with pathologic stage IIIA and IIIB disease. For clarifying this problem, the present study was constructed in light of T3 and T4 classifications.
Methods: Among 429 patients with non-small cell lung cancer who underwent resection, those with stage IIIA (n = 73) and stage IIIB (n = 79) disease were enrolled in this study, and their prognostic factors were compared.
Results: No difference in the survivals between patients with T3 and T4 disease was observed, and this seemed to affect the prognoses of patients with stage IIIA and IIIB disease. However, when those with T3 and T4 disease were classified into different groups on the basis of TNM descriptors, differences in the survivals became evident. The T3 bronchial invasion group showed a better prognosis than the T3 extrapulmonary invasion group. The T4 tracheal invasion group and T4 pulmonary metastasis group showed a significantly better prognosis than that in the T4 extrapulmonary invasion group and the T4 malignant pleural exudate group. The surgical curativity of patients with T3 disease was evaluated as curative resection or noncurative resection, and the surgical curativity of T4 was evaluated as R0 resection or R1 or R2 resection. The T3 bronchial invasion group included more curative resection cases. The T4 tracheal invasion group and T4 pulmonary metastasis group included more R0 resection cases. Furthermore, when patients with T3 to T2 bronchial invasion and patients with T4 tracheal invasion and T4 pulmonary metastasis were reclassified as having T3 disease, the survivals of the patients reclassified as having T3 and T4 disease, as well as the resultant subsets having stage IIIA and IIIB disease, were significantly different.
Conclusion: Tumor status should be reviewed by taking into account the surgical curativity.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Kameyama, M. Takahashi, K. Ohata, H. Igai, A. Yamashina, T. Matsuoka, T. Nakagawa, and N. Okumura
Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1180 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Fukui, S. Mori, S. Hatooka, M. Shinoda, and T. Mitsudomi
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non-small cell lung cancers.
J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1343 - 1348.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Aokage, G. Ishii, K. Nagai, O. Kawai, Y. Naito, T. Hasebe, M. Nishimura, J. Yoshida, and A. Ochiai
Intrapulmonary metastasis in resected pathologic stage IIIB non small cell lung cancer: Possible contribution of aerogenous metastasis to the favorable outcome
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 386 - 391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Chong, T. S. Kim, and J. Han
Tracheal Metastasis of Lung Cancer: CT Findings in Six Patients
Am. J. Roentgenol., January 1, 2006; 186(1): 220 - 224.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Bronchogenic Carcinoma Cooperative Group of the Sp
Survival of 2,991 Patients With Surgical Lung Cancer: The Denominator Effect in Survival
Chest, October 1, 2005; 128(4): 2274 - 2281.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.